← Back to Search

Meal Timing for High Blood Pressure

N/A

Waitlist Available

Led By Danielle Kirkman

Research Sponsored by Virginia Commonwealth University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 hours

Awards & highlights

Study Summary

This trial looks at how eating at the wrong time affects blood pressure, kidney and vascular health.

Who is the study for?

This trial is for men and women aged 18-45 with slightly elevated or stage 1 high blood pressure. It's not for smokers, those using melatonin, pregnant or breastfeeding individuals, recent travelers across time zones, antioxidant users who can't stop during the study, people unable to consent, chronic disease sufferers, those on blood pressure meds, insomniacs, intermittent fasters in the past six months, shift workers or hormone therapy patients.Check my eligibility

What is being tested?

The study examines how eating meals at different times (morning vs. evening) affects blood pressure and kidney and vascular function in individuals with high blood pressure.See study design

What are the potential side effects?

Since this trial involves meal timing rather than medication or invasive procedures, side effects may be minimal but could include temporary changes in energy levels or digestion due to altered meal schedules.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Urinary sodium excretion and markers of kidney injury

Secondary outcome measures

24hr ambulatory blood pressure

Macrovascular function

Microvascular function

Trial Design

2Treatment groups

Experimental Treatment

Group I: Morning Meal ChallengeExperimental Treatment1 Intervention

Group II: Late Night Meal ChallengeExperimental Treatment1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor

699 Previous Clinical Trials

22,885,030 Total Patients Enrolled

Danielle KirkmanPrincipal InvestigatorVirginia Commonwealth University

1 Previous Clinical Trials

30 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can elderly patients aged 70 and over participate in this clinical research?

"This trial has set age limits of 18 years old and 45 years old as the boundaries for enrollment."

Answered by AI

Is there still an opportunity for individuals to participate in this research?

"Clinicaltrials.gov verifies that this medical trial is currently in the process of patient recruitment, having been first posted on September 11th 2023 and last edited on the 27th day of that same month."

Answered by AI

How many participants are currently engaged in this trial?

"Affirmative. Clinicaltrials.gov reports that this research initiative, initially posted on the 11th of September 2023, is currently recruiting participants. 14 individuals need to be found between 1 site for successful participation in this trial."

Answered by AI

Who has the opportunity to partake in this research initiative?

"14 individuals with hypertension between the ages of 18 and 45 have been invited to participate in this clinical trial. To be accepted, males and females must meet the following criteria: Systolic Blood Pressure (SBP) 120-129 mmHg & Diastolic Blood Pressure (DBP) <80 mmHg or SBP 130-139 mmHg & DBP 80-89 mmHg."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Chronobiology of Meal Timing: Effects on Vascular and Renal Function

2023. "Chronobiology of Meal Timing: Effects on Vascular and Renal Function". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05987566.